학술논문

HARMONi-3: A randomized, controlled, multiregional Phase 3 study of ivonescimab combined with chemotherapy versus pembrolizumab combined with chemotherapy for the first-line treatment of metastatic squamous non-small cell lung cancer
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2023, 22 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514